Koninklijke Philips N.V. (PHIA.AS)
| Previous Close | 25.41 |
| Open | 25.26 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 25.26 - 25.93 |
| 52 Week Range | 15.94 - 28.14 |
| Volume | |
| Avg. Volume | 2,547,390 |
| Market Cap | 24.247B |
| Beta (5Y Monthly) | 0.69 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.83 |
| Earnings Date | Jul 29, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 12, 2022 |
| 1y Target Est | 26.60 |
GlobeNewswirePhilips presents study results at Heart Rhythm Annual Meeting demonstrating benefits of its AI-powered cardiac monitoring solutions
A cardiologist reviews an ECG readout report with AI-assisted analysis May 17, 2024 Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs Amsterdam, the Netherlands and Boston, USA – Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, is presenting new retrospective study results demonstrating the clinical and economic bene
GlobeNewswirePhilips announces exchange ratio for 2023 dividend
May 15, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that the exchange ratio for the dividend for the year 2023 is 1 new common share for every 29.2684 existing common shares. This ratio was based on the volume weighted average price on Euronext Amsterdam of May 9, 10 and 13, 2024, of EUR 24.8481 and was calculated in a manner that the gross dividend in shares will be approximately equal to EUR 0.85. As a result, Philips will issue a total number of 30,
ZacksPhilips' (PHG) Gets FDA Recall for Trilogy Ventilator Glitch
Philips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power malfunction and gets FDA Class I recall identification, as it may cause serious harm.
